Published in Anal Chem on October 15, 2003
Mass spectrometric imaging for biomedical tissue analysis. Chem Rev (2010) 2.51
Review of recent advances in analytical techniques for the determination of neurotransmitters. Anal Chim Acta (2009) 1.68
Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol (2008) 1.59
Targeted single-cell microchemical analysis: MS-based peptidomics of individual paraformaldehyde-fixed and immunolabeled neurons. Chem Biol (2012) 1.51
Profiling signaling peptides in single mammalian cells using mass spectrometry. Anal Chem (2006) 1.38
Microproteomics: analysis of protein diversity in small samples. Mass Spectrom Rev (2008) 1.26
Mass spectrometry imaging and profiling of single cells. J Proteomics (2012) 1.17
Quantitative measurements of cell-cell signaling peptides with single-cell MALDI MS. Anal Chem (2008) 1.10
SIMS and MALDI MS imaging of the spinal cord. Proteomics (2008) 1.08
The hypothalamic-neurohypophyseal system: from genome to physiology. J Neuroendocrinol (2012) 1.01
Massively parallel sample preparation for the MALDI MS analyses of tissues. Anal Chem (2006) 1.00
Single-cell metabolomics: changes in the metabolome of freshly isolated and cultured neurons. ACS Chem Neurosci (2012) 1.00
Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact. Expert Rev Proteomics (2011) 0.99
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry. Mol Cell Proteomics (2011) 0.96
Qualitative and quantitative mass spectrometry imaging of drugs and metabolites. Adv Drug Deliv Rev (2013) 0.96
Chapter 13: Imaging of cells and tissues with mass spectrometry: adding chemical information to imaging. Methods Cell Biol (2008) 0.95
MALDI mass spectrometry imaging of neuronal cell cultures. J Am Soc Mass Spectrom (2011) 0.92
Laser capture sampling and analytical issues in proteomics. Expert Rev Proteomics (2007) 0.91
Microfluidic device for the selective chemical stimulation of neurons and characterization of peptide release with mass spectrometry. Anal Chem (2012) 0.88
Probing neuropeptide signaling at the organ and cellular domains via imaging mass spectrometry. J Proteomics (2012) 0.88
Direct cellular peptidomics of hypothalamic neurons. Front Neuroendocrinol (2011) 0.88
Neuropeptidomics: mass spectrometry-based qualitative and quantitative analysis. Methods Mol Biol (2011) 0.87
From pixel to voxel: a deeper view of biological tissue by 3D mass spectral imaging. Bioanalysis (2011) 0.87
Small-volume analysis of cell-cell signaling molecules in the brain. Neuropsychopharmacology (2013) 0.86
Neuropeptide analysis with liquid chromatography-capillary electrophoresis-mass spectrometric imaging. J Sep Sci (2012) 0.84
Single Cell Peptide Heterogeneity of Rat Islets of Langerhans. ACS Chem Biol (2016) 0.82
Molecular morphology of the chick heart visualized by MALDI imaging mass spectrometry. Anat Rec (Hoboken) (2010) 0.82
Imaging MALDI mass spectrometry of sphingolipids using an oscillating capillary nebulizer matrix application system. Methods Mol Biol (2010) 0.82
Mass spectrometry-based characterization of endogenous peptides and metabolites in small volume samples. Biochim Biophys Acta (2015) 0.82
Exploring proteins in Anopheles gambiae male and female antennae through MALDI mass spectrometry profiling. PLoS One (2008) 0.81
Challenges and recent advances in mass spectrometric imaging of neurotransmitters. Bioanalysis (2014) 0.81
Matrix-Assisted Laser Desorption/Ionization (MALDI) Imaging Mass Spectrometry (IMS): A Challenge for Reliable Quantitative Analyses. Mass Spectrom (Tokyo) (2012) 0.80
Metal-assisted polyatomic SIMS and laser desorption/ionization for enhanced small molecule imaging of bacterial biofilms. Biointerphases (2016) 0.80
Mass Spectrometry of Single GABAergic Somatic Motorneurons Identifies a Novel Inhibitory Peptide, As-NLP-22, in the Nematode Ascaris suum. J Am Soc Mass Spectrom (2015) 0.75
Different neuropeptides are expressed in different functional subsets of cholinergic excitatory motorneurons in the nematode Ascaris suum. ACS Chem Neurosci (2015) 0.75
The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science (2009) 8.23
Analyses of pig genomes provide insight into porcine demography and evolution. Nature (2012) 5.58
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron (2003) 3.58
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci (2005) 3.46
Mission creep in the IRB world. Science (2006) 2.64
The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods (2008) 2.54
Genome-wide analyses reveal a role for peptide hormones in planarian germline development. PLoS Biol (2010) 2.47
Exercise, experience and the aging brain. Neurobiol Aging (2002) 2.44
Experience-driven brain plasticity: beyond the synapse. Neuron Glia Biol (2004) 2.27
From the genome to the proteome: uncovering peptides in the Apis brain. Science (2006) 2.25
MALDI-MS imaging of features smaller than the size of the laser beam. J Am Soc Mass Spectrom (2005) 2.08
Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. J Neurosci (2006) 2.04
Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. Proc Natl Acad Sci U S A (2004) 1.99
Environmental influences on cognitive and brain plasticity during aging. J Gerontol A Biol Sci Med Sci (2004) 1.99
Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc Natl Acad Sci U S A (2004) 1.97
Circadian rhythm of redox state regulates excitability in suprachiasmatic nucleus neurons. Science (2012) 1.97
Peptides in the brain: mass spectrometry-based measurement approaches and challenges. Annu Rev Anal Chem (Palo Alto Calif) (2008) 1.92
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr (2008) 1.91
Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am J Med Genet A (2005) 1.90
The Enzyme Function Initiative. Biochemistry (2011) 1.87
Storage and uptake of D-serine into astrocytic synaptic-like vesicles specify gliotransmission. J Neurosci (2013) 1.82
Achieving and maintaining cognitive vitality with aging. Mayo Clin Proc (2002) 1.81
Profiling metabolites and peptides in single cells. Nat Methods (2011) 1.79
Contributions of capillary electrophoresis to neuroscience. J Chromatogr A (2007) 1.76
Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet (2002) 1.76
Microfluidic devices for culturing primary mammalian neurons at low densities. Lab Chip (2007) 1.68
Discovering new invertebrate neuropeptides using mass spectrometry. Mass Spectrom Rev (2005) 1.66
Micromixer-based time-resolved NMR: applications to ubiquitin protein conformation. Anal Chem (2003) 1.64
Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry (2004) 1.61
Motor impairment in rats exposed to PCBs and methylmercury during early development. Toxicol Sci (2003) 1.59
Dendritic spine abnormalities in the occipital cortex of C57BL/6 Fmr1 knockout mice. Am J Med Genet B Neuropsychiatr Genet (2005) 1.55
Vitamin E imaging and localization in the neuronal membrane. J Am Chem Soc (2005) 1.52
Targeted single-cell microchemical analysis: MS-based peptidomics of individual paraformaldehyde-fixed and immunolabeled neurons. Chem Biol (2012) 1.51
Imaging mass spectrometry: fundamentals and applications to drug discovery. Drug Discov Today (2005) 1.47
Discovery of new enzymes and metabolic pathways by using structure and genome context. Nature (2013) 1.46
Discrete molecular states in the brain accompany changing responses to a vocal signal. Proc Natl Acad Sci U S A (2009) 1.46
Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc Natl Acad Sci U S A (2010) 1.45
NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucleic Acids Res (2006) 1.45
Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res (2006) 1.41
Profiling signaling peptides in single mammalian cells using mass spectrometry. Anal Chem (2006) 1.38
Altered expression of BDNF and its high-affinity receptor TrkB in response to complex motor learning and moderate exercise. Brain Res (2004) 1.33
Gateable nanofluidic interconnects for multilayered microfluidic separation systems. Anal Chem (2003) 1.30
From hunger to satiety: reconfiguration of a feeding network by Aplysia neuropeptide Y. J Neurosci (2007) 1.30
Mass spectrometric investigation of the neuropeptide complement and release in the pericardial organs of the crab, Cancer borealis. J Neurochem (2003) 1.28
Mass spectrometry-based discovery of circadian peptides. Proc Natl Acad Sci U S A (2008) 1.27
Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome. Brain Res (2003) 1.26
Microproteomics: analysis of protein diversity in small samples. Mass Spectrom Rev (2008) 1.26
Persistent impairment of hippocampal neurogenesis in young adult rats following early postnatal alcohol exposure. Alcohol Clin Exp Res (2007) 1.25
A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons. J Neurosci (2002) 1.25
Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months. Proc Natl Acad Sci U S A (2011) 1.25
Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein. Proc Natl Acad Sci U S A (2010) 1.25
Spatial profiling invertebrate ganglia using MALDI MS. J Am Soc Mass Spectrom (2003) 1.24
Experience effects on brain development: possible contributions to psychopathology. J Child Psychol Psychiatry (2003) 1.22
Quantitative peptidomics reveal brain peptide signatures of behavior. Proc Natl Acad Sci U S A (2009) 1.21
Bridging neuropeptidomics and genomics with bioinformatics: Prediction of mammalian neuropeptide prohormone processing. J Proteome Res (2006) 1.21
Capillary electrophoresis with electrospray ionization mass spectrometric detection for single-cell metabolomics. Anal Chem (2009) 1.19
A protease for 'middle-down' proteomics. Nat Methods (2012) 1.19
Progress toward single cell metabolomics. Curr Opin Biotechnol (2012) 1.19
Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis. Neurobiol Learn Mem (2005) 1.18
Mass spectrometry imaging and profiling of single cells. J Proteomics (2012) 1.17
Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex. Cereb Cortex (2011) 1.15
Characterizing peptides in individual mammalian cells using mass spectrometry. Nat Protoc (2007) 1.15
Stability of synaptic plasticity in the adult rat visual cortex induced by complex environment exposure. Brain Res (2004) 1.15
Metabolic differentiation of neuronal phenotypes by single-cell capillary electrophoresis-electrospray ionization-mass spectrometry. Anal Chem (2011) 1.14
A RubisCO-like protein links SAM metabolism with isoprenoid biosynthesis. Nat Chem Biol (2012) 1.13
Neuropeptidomics of the supraoptic rat nucleus. J Proteome Res (2008) 1.13
Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome. Ment Retard Dev Disabil Res Rev (2004) 1.11
Design and fabrication of a multilayered polymer microfluidic chip with nanofluidic interconnects via adhesive contact printing. Lab Chip (2006) 1.10
Quantitative measurements of cell-cell signaling peptides with single-cell MALDI MS. Anal Chem (2008) 1.10
Single-neuron analysis using CE combined with MALDI MS and radionuclide detection. Anal Chem (2002) 1.09
Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Natl Acad Sci U S A (2008) 1.09
Orcokinin peptides in developing and adult crustacean stomatogastric nervous systems and pericardial organs. J Comp Neurol (2002) 1.09
SIMS and MALDI MS imaging of the spinal cord. Proteomics (2008) 1.08
Endogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry. Mol Cell Proteomics (2009) 1.08
Nanocapillary array interconnects for gated analyte injections and electrophoretic separations in multilayer microfluidic architectures. Anal Chem (2003) 1.07
Patch clamp electrophysiology and capillary electrophoresis-mass spectrometry metabolomics for single cell characterization. Anal Chem (2014) 1.06
Motor learning induces astrocytic hypertrophy in the cerebellar cortex. Behav Brain Res (2007) 1.05
Fragile X mental retardation protein shifts between polyribosomes and stress granules after neuronal injury by arsenite stress or in vivo hippocampal electrode insertion. J Neurosci (2006) 1.05
Myelination of the corpus callosum in male and female rats following complex environment housing during adulthood. Brain Res (2009) 1.04
Mass spectrometric imaging of peptide release from neuronal cells within microfluidic devices. Lab Chip (2007) 1.03
From precursor to final peptides: a statistical sequence-based approach to predicting prohormone processing. J Proteome Res (2003) 1.03
Intraspecific variation of venom injected by fish-hunting Conus snails. J Exp Biol (2005) 1.02
Circadian integration of glutamatergic signals by little SAAS in novel suprachiasmatic circuits. PLoS One (2010) 1.02
Plasticity of nonneuronal brain tissue: roles in developmental disorders. Ment Retard Dev Disabil Res Rev (2004) 1.02
Altered mossy fiber distributions in adult Fmr1 (FVB) knockout mice. Hippocampus (2002) 1.01
Massively parallel sample preparation for the MALDI MS analyses of tissues. Anal Chem (2006) 1.00
Molecular organization of Drosophila neuroendocrine cells by Dimmed. Curr Biol (2011) 1.00
Single-cell metabolomics: changes in the metabolome of freshly isolated and cultured neurons. ACS Chem Neurosci (2012) 1.00
Determining sequences and post-translational modifications of novel conotoxins in Conus victoriae using cDNA sequencing and mass spectrometry. J Mass Spectrom (2004) 1.00
The zebra finch neuropeptidome: prediction, detection and expression. BMC Biol (2010) 0.99
Microfluidic separation and gateable fraction collection for mass-limited samples. Anal Chem (2004) 0.99
Prediction of neuropeptide prohormone cleavages with application to RFamides. Peptides (2006) 0.99
Interfering with nitric oxide measurements. 4,5-diaminofluorescein reacts with dehydroascorbic acid and ascorbic acid. J Biol Chem (2002) 0.99
Mandatory " enriched" housing of laboratory animals: the need for evidence-based evaluation. ILAR J (2005) 0.98
Engineering the morphology and electrophysiological parameters of cultured neurons by microfluidic surface patterning. FASEB J (2004) 0.98
Aplysia bag cells function as a distributed neurosecretory network. J Neurophysiol (2007) 0.98
Developmental characteristics of dendritic spines in the dentate gyrus of Fmr1 knockout mice. Brain Res (2010) 0.97
Profiling pH gradients across nanocapillary array membranes connecting microfluidic channels. J Am Chem Soc (2005) 0.97